GlaxoSmithKline Intellectual Property Development Limited et al v. Transpire Bio Inc.
| GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC and Glaxo Group Limited |
| Transpire Bio Inc. |
| 0:2026cv60696 |
| March 6, 2026 |
| U.S. District Court for the Southern District of Florida |
| Roy K Altman |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 0145 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 17, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 24
PAPERLESS ORDER granting Motions to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing [ECF Nos. 13-23] as to: Bansri R. Patel, James M. Lyons, Lisa J. Pirozzolo, Christopher R. Noyes, Gabriel Rosanio, Lance M. Peterzell, Laura Macro, Lauren E. Matlock-Colangelo, Robert J. Gunther, Jr., Stephanie M. Zielinski, and Tammy Terry. Signed by Judge Roy K. Altman on 3/17/2026. (pbe)
|
| Filing 23 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Tammy Terry. Filing Fee $ 250.00 Receipt # AFLSDC-19318029 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 22 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Stephanie M. Zielinski. Filing Fee $ 250.00 Receipt # AFLSDC-19317930 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 21 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Robert J. Gunther, Jr.. Filing Fee $ 250.00 Receipt # AFLSDC-19317873 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 20 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Lauren E. Matlock-Colangelo. Filing Fee $ 250.00 Receipt # AFLSDC-19317826 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 19 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Laura Macro. Filing Fee $ 250.00 Receipt # AFLSDC-19317789 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 18 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Lance M. Peterzell. Filing Fee $ 250.00 Receipt # AFLSDC-19317770 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 17 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Gabriel Rosanio. Filing Fee $ 250.00 Receipt # AFLSDC-19317700 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 16 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Christopher R. Noyes. Filing Fee $ 250.00 Receipt # AFLSDC-19317669 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 15 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Lisa J. Pirozzolo. Filing Fee $ 250.00 Receipt # AFLSDC-19317593 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 14 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for James M. Lyons. Filing Fee $ 250.00 Receipt # AFLSDC-19317552 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 13 MOTION to Appear Pro Hac Vice, Consent to Designation, and Request to Electronically Receive Notices of Electronic Filing for Bansri R. Patel. Filing Fee $ 250.00 Receipt # AFLSDC-19317436 by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/30/2026. (Attachments: #1 Text of Proposed Order Proposed Order)(Raymond, Mark) |
| Filing 12 FORM AO 120 SENT TO DIRECTOR OF U.S. PATENT AND TRADEMARK (AO Form, Complaint and Exhibits sent) (Attachments: #1 Complaint and Exhibits) (ebz) |
|
Filing 11
ORDER. The Clerk is DIRECTED to CLOSE this case (26cv21512) and OPEN this case as a new case (26cv60696) assigned to the Honorable Roy K. Altman in our Ft. Lauderdale division. Signed by Judge Roy K. Altman on 3/10/2026. See attached document for full details. (ebz)
|
| Filing 10 WAIVER OF SERVICE Returned Executed by GlaxoSmithKline Intellectual Property Development Limited, Glaxo Group Limited, GlaxoSmithKline LLC. Transpire Bio Inc. waiver sent on 3/10/2026, response/answer due 5/11/2026. (Woods, Michael) |
| Filing 9 Notice of Pending, Refiled, Related or Similar Actions by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC (Woods, Michael) |
| Filing 8 Plaintiff's Corporate Disclosure Statement PLAINTIFFS RULE 7.1 CORPORATE DISCLOSURE STATEMENT by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC identifying Corporate Parent GlaxoSmithKline Holdings (Americas) Inc., Corporate Parent GSK plc for GlaxoSmithKline LLC; Corporate Parent GSK plc, Corporate Parent GlaxoSmithKline Intellectual Property Management Limited for GlaxoSmithKline Intellectual Property Development Limited ; Corporate Parent GlaxoSmithKline Finance plc, Corporate Parent GSK plc for Glaxo Group Limited (Woods, Michael) |
| Filing 7 Bar Letter re: Admissions sent to attorney Robert J. Gunther, Christopher R. Noyes, Laura Macro, Gabriel Rosanio, Lance M. Peterzell, Stephanie M. Zielinski, Lisa J. Pirozzolo, James M. Lyons, Bansri R. Patel, Tammy Terry, and Lauren E. Matlock-Colangelo mailing date March 9, 2026, (pt) |
| Filing 6 Plaintiff's MOTION to Change Venue from the Miami-Dade County Division to the Broward County Division by Glaxo Group Limited, GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline LLC. Responses due by 3/20/2026. (Woods, Michael) |
| Filing 5 Clerk's Notice to Filer re: Electronic Case. Venue on the Civil Cover Sheet does not match the initiating document. The Clerks Office confirmed Miami-Dade (Office - Miami) as the county with the filer. It is not necessary to re-file this document. (cwc) |
| Filing 4 FORM AO 120 SENT TO DIRECTOR OF U.S. PATENT AND TRADEMARK (Attachments: #1 Complaint and Exhibit) (cwc) |
| Filing 3 Summons Issued as to Transpire Bio Inc.. (cwc) |
| Filing 2 Clerks Notice of Judge Assignment to Judge Roy K. Altman. Pursuant to 28 USC 636(c), the parties are hereby notified that the U.S. Magistrate Judge Enjolique A. Lett is available to handle any or all proceedings in this case. If agreed, parties should complete and file the Consent form found on our website. It is not necessary to file a document indicating lack of consent. (cwc) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT against TRANSPIRE BIO INC.. Filing fees $ 405.00 receipt number AFLSDC-19289768, filed by GlaxoSmithKline Intellectual Property Development Limited, Glaxo Group Limited, GlaxoSmithKline LLC. (Attachments: #1 Civil Cover Sheet, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E, #7 Exhibit F, #8 Exhibit G, #9 Exhibit H, #10 Exhibit I, #11 Exhibit J, #12 Exhibit K, #13 Exhibit L, #14 Summon(s))(Raymond, Mark) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
